References
- Delmas P D. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol Metab Clin North Am 1990; 19: 1–18
- Schiele F, Henry J, Hitz S, Petitclerc C, Gueguen R, Siest G. Total, bone and liver alkaline phosphatases in plasma: biological variation and reference limits. Clin Chem 1983; 23: 634–41
- Delmas P D. Marqueurs biologiques du métabolisme osseux. Presse Méd 1993; 22: 263–68
- Garnero P, Grimaux M, Demiaux B, Préaudat C, Seguin P, Delmas P D. Measurement of serum osteocalcin with a human-specific immunoradiometric assay. J Bone Min Res 1992; 7: 1389–98
- Van Hoof V O., Hoylarts M S., Geryl H, Van Mullem M, Lepoutre L G., Broe M E. Age and sex distribution of alkaline phosphatase isoenzymes by electrophoresis. Clin Chem 1990; 36: 875–8
- Garnero P, Delmas P D. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab. 1993; 77: 1046–53
- Delmas P D. Use of biochemical markers of bone remodelling in osteoporosis. Bone 1992; 13: 17–21
- Delmas P D. Biochemical markers of bone turnover in osteoporosis. Osteoporosis. Etiology, diagnosis and management, B L. Riggs, L J. Melton, III. Raven Press, New York 1988; 297
- Haarbo J, Christiansen C. Treatment-induced cyclic variations in serum lipids, lipoproteins, and apolipoproteins after 2 years of combined hormone replacement therapy: exaggerated cyclic variations in smokers. Obstet Gynecol 1992; 80: 639–44
- Johansen J S., Mølholm-Hansen J E., Christiansen C. A radioimmunoassay for bone Gla protein (BGP) in human plasma. Acta Endocrinol 1987; 114: 410–16
- Behr W, Barnert J. Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ lectin: a simplified method and its clinical plausibility. Clin Chem 1986; 32: 1960–6
- Rosalki S B., Foo A Y. Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem 1984; 30: 1182–6
- Riis B J., Thomsen K, Strøm V, Christiansen C. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol 1987; 156: 61–5
- Christiansen C, et al. Conference report: Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993; 94: 797–805
- Dempster D W., Lindsay R. Pathogenesis of osteoporosis. Lancet 1993; 341: 797–805
- Lang P, Steiger P, Faulkner K, Gluer C, Genant P. Osteoporosis. Current techniques and recent developments in quantitative bone densitometry. Radiol Clin North Am 1991; 29: 49–76
- Panigrahi K, Delmas P D., Singer F, Ryan W, Reiss O, Fisher R, et al. Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum. Clin Chem 1994; 40: 822–8
- Riis B J. Biochemical markers–a new approach for identifying those at risk of osteoporosis. Baillières Clin Obstet Gynecol 1991; 5: 831–6
- Delmas P D., Schlemmer A, Gineyts E, Riis B J., Christiansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Min Res 1991; 6: 639–44
- Pathemore J G., Burton D W., Deftos L J. Associations and dissociations between serum Gla protein and alkaline phosphatase in skeletal metabolism. J Orthopaed Res 1993; 11: 671–6
- Garrido J C., Aguayo F J., Moreno C A. Comparison of three bone alkaline phosphatase quantification methods in patients with increased alkaline phosphatase activities. Clin Chem 1992; 38: 1165–6